Gillson Sciences provides microbiological testing services that help life sciences organizations detect contamination risks and maintain product quality and regulatory compliance. Our GxP-qualified experts deliver microbiological analysis at every stage of the pharmaceutical, healthcare, and medical device continuum — and our microbiological testing services often work alongside environmental monitoring and analytical testing to support comprehensive contamination control programs. We manage the entire process, from coordinating logistics to delivering precise, timely, and reliable results. Our goal is to provide actionable data that safeguards products, supports compliance, and keeps your operations running smoothly. Microbiological testing programs often align with regulatory standards such as USP microbial limits testing and FDA GMP guidance to ensure defensible, inspection-ready results. Microbiological testing evaluates pharmaceutical, medical device, and healthcare products for microbial contamination, sterility, and endotoxin levels. It is a critical requirement for product release, regulatory compliance, and patient safety. Gillson Sciences performs USP <61>, <62>, <71>, <85>, <51>, <1113>, and other compendial methods, as well as AAMI/ISO bioburden and sterilization validation standards. We serve pharmaceutical, biopharmaceutical, medical device, healthcare, nutritional science, and cosmetic organizations requiring GxP-compliant microbiological testing services.
